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Abstract
Based on epidemiological data, it is believed that human-to-human transmission plays an important role in Nipah virus
outbreaks. No experimental data are currently available on the potential routes of human-to-human transmission of Nipah
virus. In a first dose-finding experiment in Syrian hamsters, it was shown that Nipah virus was predominantly shed via the
respiratory tract within nasal and oropharyngeal secretions. Although Nipah viral RNA was detected in urogenital and rectal
swabs, no infectious virus was recovered from these samples, suggesting no viable virus was shed via these routes. In
addition, hamsters inoculated with high doses shed significantly higher amounts of viable Nipah virus particles in
comparison with hamsters infected with lower inoculum doses. Using the highest inoculum dose, three potential routes of
Nipah virus transmission were investigated in the hamster model: transmission via fomites, transmission via direct contact
and transmission via aerosols. It was demonstrated that Nipah virus is transmitted efficiently via direct contact and
inefficiently via fomites, but not via aerosols. These findings are in line with epidemiological data which suggest that direct
contact with nasal and oropharyngeal secretions of Nipah virus infected individuals resulted in greater risk of Nipah virus
infection. The data provide new and much-needed insights into the modes and efficiency of Nipah virus transmission and
have important public health implications with regards to the risk assessment and management of future Nipah virus
outbreaks.
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Introduction
Nipah virus is a member of the Henipavirus genus in the
Paramyxoviridae family. Nipah virus first emerged in humans in
Malaysia in 1998–1999, during a large outbreak of encephalitis
and respiratory disease in humans, causing 276 cases of
encephalitis, with 106 fatalities [1]. The subsequent detection of
antibodies against Nipah virus, Nipah viral RNA and the isolation
of Nipah virus from samples of Pteropus spp fruit bats indicated
that they form the natural reservoir of Nipah virus [2,3,4,5]. In
Malaysia, Nipah virus-infected pigs formed the intermediate and
amplifying host in the transmission cycle from the natural reservoir
to humans [6]. The second Nipah virus outbreak occurred in India
in 2001, resulting in 66 cases of encephalitis with a case-fatality of
74% [7]. Epidemiological data suggest that 75% of the Nipah
virus patients in this outbreak were exposed to the virus within a
hospital setting, with human-to-human transmission as the most
likely route [7]. Since 2001, outbreaks of Nipah virus have
occurred almost every year in Bangladesh. Clinical presentation of
Nipah virus in Bangladesh is somewhat different from that in
Malaysia, with a higher proportion of respiratory disease and a
higher case-fatality rate of up to 90% [8]. No intermediate host
was implicated in the Nipah virus outbreaks in India and
Bangladesh. Rather, epidemiological data suggest transmission of
Nipah virus from bats to humans through the consumption of fruit
or date palm sap contaminated by infected fruit bats [9,10]. In
addition, human-to-human transmission occurred on a larger scale
during outbreaks in India and Bangladesh compared to Malaysia.
For the Nipah virus outbreaks in Bangladesh between 2001 and
2007, it was estimated that ,50% of Nipah virus cases were the
result of human-to-human transmission events [11]. Since such a
large proportion of Nipah cases was likely the result of human-to-
human transmission it is important to understand the mode of
transmission of Nipah virus and implement measures to prevent it
in future outbreaks. Nipah virus has been isolated from human
urine, saliva, nasal and oropharyngeal secretions and epidemio-
logical data suggest that direct contact with these secretions of
Nipah virus spreaders resulted in greater risk of Nipah virus
infection. Three potential modes of human-to-human transmission
of Nipah virus could be transmission via fomites, direct contact or
aerosols.
In this study we assessed the potential of human-to-human
transmission of Nipah virus in the Syrian hamster model. The
Syrian hamster has been shown to replicate both the respiratory
and neurological symptoms seen in humans [12,13]. Through
systematic transmission studies in the Syrian hamster model, we
show that direct contact is the most efficient route of Nipah virus
transmission.
Methods
Ethics statement
All animal experiments were approved by the Institutional
Animal Care and Use Committee of the Rocky Mountain
www.plosntds.org 1 December 2011 | Volume 5 | Issue 12 | e1432Laboratories (ASP #2011-03), and performed following the
guidelines of the Association for Assessment and Accreditation of
Laboratory Animal Care, International (AAALAC) by certified
staff in an AAALAC-approved facility.
Virus and cells. Nipah virus (strain Malaysia) was kindly
provided by the Special Pathogens Branch of the Centers for
Disease Control and Prevention, Atlanta, Georgia, United States
and propagated in VeroE6 cells in DMEM (Sigma) supplemented
with 10% fetal calf serum (Hyclone, Logan), 1 mM L-glutamine
(Lonza), 50 U/ml penicillin and 50 mg/ml streptomycin (Gibco).
Animal experiments
To study the relation between inoculation dose and Nipah virus
shedding, 3 groups of 18 6–8 week old female Syrian hamsters
(HsdHan
tm:AURA, Harlan Laboratories) were inoculated intra-
nasally with 10
3,1 0
5 or 10
7 TCID50 of Nipah virus in a total
volume of 100 ml. On days 2 and 4 post inoculation 6 animals
were euthanized and lungs, trachea and nasal turbinates were
collected for virologic and histopathologic analysis. Daily nasal,
oropharyngeal, urinogenital and rectal swabs were obtained from
the remaining 6 hamsters. Swabs were collected in vials containing
1 ml DMEM supplemented with 50 U/ml penicillin and 50 mg/
ml streptomycin. Hamsters were euthanized on day 14 post
inoculation or earlier upon signs of severe infection.
For fomite transmission experiments, eight 6–8 week old female
singly housed Syrian hamsters, housed in a plastic cage with wood
shavings, a feeder and a water bottle, were inoculated intranasally
with 10
7 TCID50 in a total volume of 100 ml. Nasal and
oropharyngeal swabs were obtained daily to monitor the infectious
status. On day 4 post inoculation, hamsters were euthanized and a
single naı ¨ve hamster was placed in each cage. Bodyweight of these
hamsters was determined daily and nasal and oropharyngeal
swabs were taken until swabs were PCR-negative on three
consecutive days. Naı ¨ve hamsters were euthanized upon signs of
severe disease or four weeks post exposure.
For direct contact transmission experiments, eight 6–8 week old
female singly housed Syrian hamsters were inoculated intranasally
with 10
7 TCID50 in a total volume of 100 ml. On day 1 post
inoculation, a naı ¨ve hamster was added to each cage. Nasal and
oropharyngeal swabs were obtained from inoculated and naı ¨ve
hamsters daily and bodyweight of naı ¨ve hamsters was determined.
On signs of severe disease, inoculated and naı ¨ve hamsters were
euthanized; remaining hamsters were euthanized four weeks post
exposure.
For aerosol transmission experiments, eight 6–8 week old female
Syrian hamsters were inoculated intranasally with 10
7 TCID50 in
a total volume of 100 ml and singly housed in specially designed
aerosol transmission cages. On day 1 post inoculation, a naı ¨ve
hamster was placed on the opposite side of the inoculated hamster.
The hamsters were separated by two stainless steel grids, allowing
airflow from the inoculated to the naive hamster but preventing
direct contact and fomite transmission. Nasal and oropharyngeal
swabs were obtained from inoculated and naı ¨ve hamsters daily
and bodyweight of naı ¨ve hamsters was determined. On signs of
severe disease, inoculated and naı ¨ve hamsters were euthanized;
remaining hamsters were euthanized four weeks post exposure.
Virus titrations
Virus titrations were performed by end-point titration in
VeroE6 cells. VeroE6 cells were inoculated with tenfold serial
dilutions of swab medium or tissue homogenates. One hour after
inoculation, the inoculum was removed and replaced with 200 ml
DMEM supplemented with 10% fetal calf serum (Hyclone,
Logan), 1 mM L-glutamine (Lonza), 50 U/ml penicillin and
50 mg/ml streptomycin (Gibco). Three days after inoculation,
cytopathic effect (CPE) was scored and the TCID50 was calculated
from 5 replicates by the method of Spearman-Karber. Tissue
homogenates were prepared by adding 1 ml DMEM to the
weighed tissue and homogenizing using a TissueLyzer II (Qiagen).
Homogenates were centrifuged to clear the homogenate before
inoculating cells.
Histopathology and immunohistochemistry
Histopathology and immunohistochemistry was performed on
hamster tissues. Anaesthetized hamsters were euthanized by
exsanguination. Necropsies and tissue sampling were performed
according to a standard protocol approved by the Institutional
Biosafety Committee. After fixation for 7 days in 10% neutral-
buffered formalin and embedding in paraffin, tissue sections were
stained with hematoxylin and eosin (H&E) staining and an
immunohistochemical method using a rabbit polyclonal antiserum
against the Nipah virus nucleoprotein [14] (1:5000; kindly
provided by L. Wang, CSIRO Livestock Industries, Australian
Animal Health Laboratory, Australia) as a primary antibody for
detection of Nipah virus antigen. For the histopathological analysis
of the nasal turbinates (NT) whole hamster skulls were used. The
skulls were decalcified using a 20% EDTA solution in sucrose
(Newcomer Supply) and allowed to sit at room temperature for 3
weeks. The 20% EDTA/sucrose solution was changed62 prior to
gross sectioning the skull. The following tissues were examined:
NT, trachea and lungs. Lesions were assigned a subjective score
from 0 to 4 based on the percentage of the tissue that was
immunopositive. The slides were evaluated by a veterinary
pathologist.
Quantitative PCR
RNA was extracted from swab samples using the NucleoSpin 96
Virus Core kit (Macherey-Nagel) and a Corbett Robotics model
CAS 1820 automatic RNA extractor. RNA was eluted in 100 ml.
5 ml RNA was used in a one-step real-time RT-PCR targeted at
the NP gene using the Rotor-Gene
TM probe kit (Qiagen)
according to instructions of the manufacturer (primer sequences
Author Summary
Understanding how viruses are transmitted plays an
important role in our ability to intervene in virus outbreaks.
Over the last decade, Nipah virus has caused multiple
outbreaks in Malaysia, India and especially Bangladesh.
Fruit bats form the natural reservoir for Nipah virus; from
the bats the virus is introduced into the human
population, either directly or via an intermediate host.
Epidemiological data suggest that upon introduction into
the human population the virus has the ability to spread
from person-to-person. We performed experimental stud-
ies in a hamster model to investigate if we could mimic
human-to-human transmission and to determine the route
of transmission through which Nipah virus spread
between people. We discovered that Nipah virus-infected
hamsters predominantly shed virus via excretions from the
nose and lungs. In transmission experiments, we showed
that Nipah virus is efficiently transmitted via direct contact.
Fomite transmission was inefficient and transmission via
aerosols did not occur. The elucidation of the mode of
Nipah virus transmission has important public health
implications because it allows a targeted and experi-
ment-based assessment of intervention strategies and
surveillance for emerging Nipah virus strains better
adapted to human-to-human transmission.
Nipah Virus Transmission
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titered virus stock were run in parallel, to calculate TCID50
equivalents in the samples.
Virus neutralization assay
Two-fold serial dilutions of heat-inactivated hamster sera were
prepared in DMEM containing 2% fetal calf serum, 1 mM L-
glutamine, 50 U/ml penicillin and 50 mg/ml streptomycin and
100 TCID50 of Nipah virus was added. After 1 hr at 37uC, this
mix was added toVeroE6 cells. Three days after inoculation, wells
were scored for CPE. The virus neutralization titer was expressed
as the reciprocal value of the highest dilution of the serum, which
still inhibits Nipah virus replication.
ELISA
Immuno-globulin G antibody responses were measured in an
enzyme-linked immunosorbent assay (ELISA) using Nipah virus
Malaysia. Nipah virus-containing cell culture supernatant was
concentrated and purified by spinning two hours at 21000 rpm
over a 20% sucrose cushion. The pellet was resuspended in PBS
and triton X-100 was added to a final concentration of 1%. This
suspension was then used to coat immuno 96 microwell maxisorp
plates (NUNC) at 4uC overnight. Subsequently, plates were
blocked with 5% skim milk in PBS containing 0.05% Tween 20
(PBST) for 1.5 hours at 4uC. After 3 washes with PBST, 50 mLo f
diluted serum samples were added, and the plates were incubated
for 1 hour at 37uC. Bound antibodies were detected after 3 washes
using an anti-hamster secondary antibody conjugated with
horseradish peroxidase (HRP; KPL). Following incubation for
1 hour at 37uC, bound HRP was detected using the ABTSH
Peroxidase Substrate System (KPL). The absorbance at 405 nm
was measured using a microplate spectrophotometer. Sera were
considered positive when absorbance was higher than three
standard deviations above the mean of negative control sera.
Results
Shedding of Nipah virus in infected hamsters
In order to determine the dose of Nipah virus to be used for
transmission experiments, hamsters were inoculated intranasally
with three different doses of the Malaysia strain of Nipah virus,
10
3,1 0
5 or 10
7 TCID50, to select the dose that resulted in the
highest amount of Nipah virus shed from the nose, throat,
urogenital tract and rectum. Upon intranasal inoculation of
hamsters with 10
3 TCID50, limited shedding of Nipah virus was
observed in nasal, oropharyngeal, urogenital tract and rectal swabs
in five out of six hamsters (Figures 1 and S1). One out of six
hamsters did not shed any Nipah virus during the 14 days duration
of the experiment. Two out of 6 hamsters showed weight loss in
the days before presentation of neurological signs and were
euthanized according to humane endpoint scoring criteria on days
8 and 14 post inoculation (Figure S2). The remaining three
hamsters all shed virus on several days, although not all four swabs
per time point were positive for all hamsters.
With a dose of 10
5 TCID50 of Nipah virus, 5 out of 6 hamsters
lost bodyweight; 2 hamsters survived until the end of the
experiment on 14 dpi, the other four hamsters had to be
euthanized due to severity of disease on 9 (three hamsters) and
12 dpi (Figure S2). In real-time RT-PCR, all six hamsters had
positive nasal, oropharyngeal, urogenital and rectal swabs
(Figures 1 and S1), starting at 2 dpi for the nasal shedding,
1 dpi for the oropharyngeal shedding, 3 dpi for the urogenital
shedding and 2 dpi for the rectal shedding (Figure 1). Viral load in
the oropharyngeal swabs was highest compared to the swabs
obtained from the other orifices.
Upon inoculation with 10
7 TCID50 of Nipah virus, hamsters
had to be euthanized due to severity of disease on days 4 and 5
post inoculation (Figure S2). Virus shedding was observed starting
at 1 dpi for all hamsters and all four swabs. Viral load in throat,
nose, urogenital and rectal swabs were significantly higher for
animals inoculated with 10
7 TCID50 than from animals inoculated
with either 10
3 TCID50 or 10
5 TCID50 of Nipah virus (2-way
ANOVA, nose p,0.001, throat p,0.001, urogenital p,0.001
and rectal p,0.001, for both 10
7 TCID50 vs 10
3 TCID50 vs and
10
7 TCID50 vs 10
5 TCID50).
Virus titrations were performed on all PCR-positive swabs. For
all infectious doses, urogenital and rectal swabs were negative
upon virus titration. Upon inoculation with 10
3 or 10
5 TCID50 of
Nipah virus, only oropharyngeal swabs were positive (Figure 2).
With a dose of 10
3 TCID50 only four swabs were positive, three of
which in the animal that was euthanized on day 8. On day 2–5
post inoculation, oropharyngeal swabs of all six animals inoculated
with 10
5 TCID50 of Nipah virus were positive in virus titrations.
With a dose of 10
7 TCID50, Nipah virus could be detected in the
nasal swabs of 5 out of 6 hamsters; oropharyngeal swabs of all
hamsters were positive in virus isolation (Figure 2). Comparison of
the total amounts of virus shed during the oropharyngeal shedding
period indicated that a significantly higher amount of virus was
shed with a dose of 10
7 TCID50 compared to either of the two
other doses in the first 4 dpi (area under curve analysis 0.2639
(95% confidence intervals of 20.2322 and 0.7600) for 10
3 TCID50
vs. 4.958 (95% confidence intervals of 3.040 and 6.875) for 10
5
TCID50 vs 7.44 (95% confidence intervals of 5.809 and 9.079) for
10
7 TCID50, 1-way ANOVA p,0.0001).
On 2 and 4 dpi, 6 hamsters of each group were euthanized and
virus titers in the nasal turbinates, trachea and lungs were
determined for 3 of these animals; the remaining three hamsters
were used for histopathological analyses. Only with the inoculum
of 10
7 TCID50 could Nipah virus be isolated in all three tissues of
all three hamsters. The inoculum of 10
7 TCID50 of Nipah virus
showed significantly higher virus titers for 2 dpi and 4 dpi
compared to the other 2 inoculum doses (2-way ANOVA, nasal
turbinates 10
3 TCID50 vs. 10
7 TCID50,p ,0.0001 and 10
5
TCID50 vs. 10
7 TCID50,p ,0.0001, trachea 10
3 TCID50 vs. 10
7
TCID50,p ,0.01 and 10
5 TCID50 vs. 10
7 TCID50,p ,0.05 and
lungs 10
3 TCID50 vs. 10
7 TCID50,p ,0.0001 and 10
5 TCID50 vs.
10
7 TCID50,p ,0.0001 (Figure 3)).
In agreement with the absence of Nipah virus titers in the nasal
turbinates, trachea and lungs of hamsters inoculated with 10
3
TCID50 of Nipah virus did not show any pathological changes at
2 dpi (Table 1). One hamster showed a small number of alveolar
epithelial cells and fewer macrophages in the lungs positive for
Nipah viral antigen. At 4 dpi, one hamster showed moderate
bronchointerstitial pneumonia characterized by multifocal bron-
chiolar epithelial degeneration and loss with thickening of adjacent
alveolar septae by edema, fibrin and small numbers of neutrophils,
macrophages and lymphocytes. One hamster inoculated with 10
5
TCID50 of Nipah virus had a minimal bronchointerstitial
pneumonia and associated viral antigen at 2 dpi and one animal
had detectable viral antigen in the epithelium of the nasal
turbinates (Table 1). At 4 dpi every hamster had acute rhinitis of
both respiratory and olfactory epithelium, in two animals with
associated viral antigen and one animal displayed mild multifocal
bronchointerstitial pneumonia. The hamsters inoculated with 10
7
TCID50 of Nipah virus demonstrated mild to moderate acute and
necrotizing rhinitis in both respiratory and olfactory epithelium
along with associated viral antigen at 2 dpi. All animals had
Nipah Virus Transmission
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viral antigen. Similar pulmonary lesions were seen at day 4 dpi
(Table 1, Figure 4). When comparing the different inoculum doses
there was a clear dose effect with the higher dose inducing rhinitis
and bronchointerstitial pneumonia at an earlier time frame when
compared to the lower and intermediate doses (Table 1).
Fomite transmission
Based on the results of the studies described above, which
showed significantly more Nipah virus shedding with the inoculum
of 10
7 TCID50, this dose was chosen for the following transmission
experiments. To determine whether Nipah virus can be
transmitted via fomites, eight singly housed hamsters were
inoculated intranasally with 10
7 TCID50 of Nipah virus. Nasal
and oropharyngeal swabs were obtained daily. On 4 dpi, all
inoculated hamsters were euthanized and a naı ¨ve hamster was
placed in their cage, while leaving existing bedding, food and
water bottles in place. Nasal and oropharyngeal swabs were
obtained daily from the naı ¨ve hamsters. Swabs were analyzed by
real time RT-PCR. Swabs from all eight naı ¨ve hamsters were
positive on at least 2 days (Figure 5). The naı ¨ve hamsters did not
show loss of bodyweight or other signs of disease; however, one
hamster was found dead on day 7 post exposure. Histopathology
of the respiratory tract and brain of this animal did not show any
presence of Nipah virus, suggesting an unrelated cause of death.
Remaining animals were euthanized four weeks post exposure. In
a virus neutralization assay performed on the sera from these
animals, no neutralizing antibodies against Nipah virus were
detected; nor did the sera test positive in an ELISA using whole
virus (data not shown).
Direct contact transmission
To determine whether Nipah virus can be transmitted through
direct contact, 8 singly housed hamsters were inoculated
intranasally with 10
7 TCID50 of Nipah virus. One day post
inoculation, a naı ¨ve hamster was added to each cage. The naive
hamsters did not lose bodyweight during the experiment. One
hamster showed signs of disease on 10 dpi and was euthanized.
The cause of death was not histologically apparent in this animal
and was thus likely unrelated to Nipah virus infection. Nasal and
Figure 1. Shedding of Nipah virus RNA in inoculated hamsters. Groups of 6 hamsters were inoculated intranasally with 10
3 (black bars), 10
5
(grey bars) or 10
7 TCID50 (white bars) Nipah virus. Nasal (A), oropharyngeal (B), urogenital (C) and rectal (D) swabs were collected daily and viral load
in the swabs was determined as TCID50 equivalents by real-time RT-PCR. Geometric mean viral loads are displayed; error bars indicate standard
deviation.
doi:10.1371/journal.pntd.0001432.g001
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all hamsters were positive on at least two days (Figure 5). More
swabs of the direct contact hamsters were positive than of the
fomite hamsters (35 vs. 14 for nasal swabs and 29 vs. 13 for
oropharyngeal swabs). Remaining animals were euthanized four
weeks post exposure. Upon histological examination, two hamsters
showed minimal acute interstitial pneumonia characterized by
small, nodular aggregates of macrophages and viable neutrophils
that filled alveoli and mildly thickened adjacent alveolar septa
(data not shown). In a virus neutralization assay performed on the
sera from all eight hamsters, neutralizing antibodies were detected
in three hamsters, with neutralizing titers ranging from 64–256.
These sera also contained high titer antibodies as determined by
ELISA, the remaining sera from hamsters in this group were
negative.
Aerosol transmission
To determine whether Nipah virus can be transmitted through
aerosols, eight singly housed hamsters were inoculated intranasally
with 10
7 TCID50 of Nipah virus and kept in cages with a divider.
One day post inoculation, a naı ¨ve hamster was added to the
opposite side of the divider in each cage. The divider was
specifically designed to allow airflow from the infected to the naı ¨ve
hamster, but prevent contact and fomite transmission. Hamsters
were swabbed daily. Between 4 and 7 dpi, all inoculated animals
were euthanized due to respiratory distress. Nasal and oropha-
ryngeal swabs of the naı ¨ve hamsters remained negative (Figure 5).
Naı ¨ve hamsters were euthanized four weeks post exposure. In a
virus neutralization assay performed on the sera from these
animals, no neutralizing antibodies against Nipah virus were
detected; nor did the sera test positive in an ELISA using whole
virus (data not shown).
Discussion
Since its’ first emergence in 1999, outbreaks of Nipah virus have
occurred almost every year. Introduction of Nipah virus into the
human population and subsequent transmission within the human
population appears to occur via multiple routes of introduction
and transmission. Whereas the Malaysian Nipah virus outbreak
was caused by an introduction of Nipah virus into the susceptible
swine population and was subsequently transmitted to humans [6],
the multiple outbreaks in India and Bangladesh appear to have
Figure 2. Shedding of Nipah virus from the respiratory tract. Virus titers in oropharyngeal swabs from hamsters inoculated with 10
3 TCID50
(A); virus titers in oropharyngeal swabs from hamsters inoculated with 10
5 TCID50 (B) and virus titers in oropharyngeal (C) and nasal (D) swabs from
hamsters inoculated with 10
7 TCID50. Nipah virus titers were determined on VeroE6 cells for real-time RT-PCR positive swabs by means of end-point
titration. Geometric mean titers are displayed; error bars indicate standard deviation. To calculate the geometric mean, the cutoff value was used for
negative swabs. The dotted line indicates cutoff value.
doi:10.1371/journal.pntd.0001432.g002
Nipah Virus Transmission
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reservoir without an amplifying intermediate host [9]. Based on
epidemiological data, it has been suggested that both swine-to-
human and human-to-human transmission of Nipah virus have
played a major role in past Nipah virus outbreaks [1,6,7,11,15,
16,17,18,19,20,21,22].
Currently, most data on the human-to-human transmission of
Nipah virus originate from investigations into the multiple
outbreaks in Bangladesh, where human-to-human transmission
has occurred frequently [11,15,16,17,18,20,22]. In the present
study, we have gathered scientific data that strengthen these
epidemiological observations. In a hamster model, efficient Nipah
virus transmission was observed via direct contact between
inoculated and naı ¨ve hamsters. The transmission was confirmed
by the presence of neutralizing antibodies in the naı ¨ve hamsters.
Although viral RNA was detected in nose and throat swabs
obtained from naı ¨ve hamsters during the fomite transmission
experiment, no virus replication or neutralizing antibodies were
detected, suggesting that although there is a potential for fomite
transmission it seemed very inefficient under the experimental
conditions of our model. Within our model, no aerosol
transmission of Nipah virus occurred as indicated by a lack of
apparent signs of disease, virus shedding, neutralizing antibodies
and presence of viral antigen in organs of exposed naı ¨ve hamsters.
In a previous study by Wong et al., transmission of Nipah virus
strain Malaysia was not observed in a hamster model upon
intraperitoneal (i.p.) inoculation with a dose of 10
5 TCID50 [13].
Virus shedding in inoculated or naı ¨ve transmission hamsters was
not tested and the absence of transmission was concluded based on
the absence of disease signs and seroconversion in the naı ¨ve
hamsters. This could either indicate that i.p. inoculation did not
result in sufficient shedding of viable virus particles to allow
transmission, since the virus would have to migrate to the nasal
cavity or urinary bladder, that transmission efficiency is dose
dependent, or a combination thereof.
Our data suggest that hamsters inoculated with 10
7 TCID50 not
only shed significantly more Nipah virus particles as determined
by realtime RT-PCR than hamsters inoculated with lower doses,
but more importantly also shed more viable Nipah virus as
determined by virus titration. With the lower inoculum doses
limited shedding of viable Nipah virus was observed, indicating
that the inoculum dose may very well affect the ability of Nipah
virus to transmit efficiently, through an effect on virus shedding.
Our results indicate the importance of nasal and oropharyngeal
shedding and transmission and are in line with previous
experimental Nipah virus infections in pigs where virus excretion
was also observed in inoculated and contact pigs, although the
mechanism by which the transmission occurred was not
investigated [23]. This suggests that the mode of transmission
from pig-to-pig, pig-to-human and human-to-human are the same
and is facilitated by direct contact with Nipah virus containing
nasal and oropharyngeal secretions.
Interestingly, epidemiological data gathered during the Nipah
virus outbreak in Malaysia have not identified human-to-human
transmission in this outbreak, although four potential cases of
nosocomial transmission have been reported [24,25]. Our results
show that Nipah virus strain Malaysia has the ability to transmit
upon contact with nasal or oropharyngeal secretions during close
social interactions. This is in agreement with the epidemiological
data suggesting that the introduction of Nipah virus in the human
population in Malaysia occurred upon direct contact with infected
swine. The absence of disease signs in hamsters that were infected
with Nipah virus via the direct contact route could be due to the
Figure 3. Nipah virus titers in respiratory tract tissues of
inoculated hamsters. Virus titers in lung, trachea and nasal turbinates
of hamsters inoculated intranasally with 10
3 (black bars), 10
5 (grey bars)
or 10
7 TCID50 (white bars) Nipah virus at 2 dpi (A) and 4 dpi (B). Nipah
virus titers were determined on VeroE6 cells by means of end-point
titration. Geometric mean titers are displayed; error bars indicate
standard deviation. To calculate the geometric mean, the cutoff value
was used for negative tissues. The dotted line indicates cutoff value.
doi:10.1371/journal.pntd.0001432.g003
Table 1. Histopathology score based on
immunohistochemistry of respiratory tissues of hamsters
inoculated with Nipah virus.
10
3 TCID50 10
5 TCID50 10
7 TCID50
2 dpi 4 dpi 2 dpi 4 dpi 2 dpi 4 dpi
Nasal
turbinates
00000001010111123
Trachea 0 0 0 0 0 1 0 0 0 0 0 1 0 1 1 1 0
Lungs 0 1 0 0 0 1 0 0 1 0 0 2 2 2 2 3 0
Hamsters were inoculated intranasally with 10
3,1 0
5 or 10
7 TCID50; three
hamsters per dose per time point were sampled except for the 10
7 TCID50
group at 4 dpi, when only 2 animals remained; each column represents one
animal.
Score: 0: no immunopositivity; 1: 1 to 25% of tissue immunopositive; 2: 26 to
50% of tissue immunopositive; 3: 51 to 75% of tissue immunopositive; 4: 76 to
100% of tissue immunopositive.
doi:10.1371/journal.pntd.0001432.t001
Nipah Virus Transmission
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virus titers shed by infected hamsters (Figure 2). As previously
shown, a low inoculum dose can result in slow progression towards
neurological disease after a limited transient respiratory infection
[12], suggesting that the contact hamsters may have been
euthanized before they presented with neurological disease signs.
This may explain the epidemiology of the Malaysian Nipah virus
outbreak, in which very limited human-to-human transmission
was observed, where patients may have experienced little
respiratory involvement and thus likely did not shed amounts of
virus sufficient for human-to-human transmission. The absence of
human-to-human transmission in the Malaysia outbreak as
compared to more prominent human-to-human transmission in
Bangladesh could potentially be caused by an intrinsic difference
in transmissibility of the respective virus [26], e.g. the ability of the
virus to efficiently replicate in humans and be shed with higher
titers could potentially facilitate more efficient human-to-human
transmission. Alternatively, different cultural or health care
practises may underlie the observed difference in human-to-
human transmission of Nipah virus strain Bangladesh and Nipah
virus strain Malaysia. Experiments to compare the transmission
efficiency of Nipah virus Bangladesh, which was not available to
us, with Nipah virus Malaysia should be performed to gain insight
in the cause of differences in observed human-to-human
transmission of Nipah virus isolated from Malaysia vs. Bangladesh.
Evidence for vertical transmission was observed in a cat model
of Nipah virus disease. In a pregnant cat, infectious virus was
detected in placental tissue and Nipah virus genomic RNA was
detected in fetal tissue [27]. Since Hendra virus has been isolated
from fetal material and uterine fluid of Pteropus bats, vertical
transmission may be an important transmission route in the
natural reservoir of Nipah and Hendra virus. It has been
suggested that Nipah virus-infected fetal tissues or fluid may play
a role in the zoonotic transmission of Nipah virus from bats to
other mammals [28,29]. Although vertical transmission of Nipah
virus in bats or incidental hosts of Nipah virus may occur, it
seems unlikely that vertical transmission would play an
important role in the perpetuation of Nipah virus outbreaks in
humans.
The experimental data on the route of transmission of Nipah
virus presented here have important public health implications
with regards to the risk assessment and management of future
Nipah virus outbreaks. In addition, this novel transmission model
can be used to evaluate the efficacy of outbreak intervention
strategies, such as vaccination and antiviral therapies. Whereas
current intervention strategies are predominantly focused at post
exposure treatment, the ability to efficiently block transmission
and thereby spread of the outbreak is currently not assessed in
antiviral or vaccination treatment strategies [14,30,31,32,33]. The
novel contact transmission model not only allows an experimental
approach to understanding the biotic and abiotic factors
underlying human-to-human transmission, but in addition might
allow incorporation of the role of foodborne transmission of Nipah
virus Bangladesh through contaminated date palm juice, that is
suggested to play a major role in the introduction of Nipah virus
into the human population in Bangladesh [9,10]. Moreover, the
hamster transmission model can be used to test the effect of
intervention strategies on the containment of the outbreak by
Figure 4. Immunohistochemical analysis of respiratory tract tissues of hamsters inoculated with Nipah virus. Hamsters were
inoculated intranasally with 10
7 TCID50 Nipah virus and respiratory samples were collected at 2 and 4 days post inoculation. Tissue sections of the
nasal turbinates (A), trachea (B), and lung (C) were stained with a monoclonal antibody against Nipah virus nucleoprotein, which is visible as a red-
brown staining.
doi:10.1371/journal.pntd.0001432.g004
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will not only contribute to the basic understanding of Nipah
transmission, it will also be of value from a public health
perspective.
Supporting Information
Figure S1 Shedding of Nipah virus RNA in inoculated
hamsters. Groups of 6 hamsters were inoculated intranasally
with 10
3 (black bars), 10
5 (grey bars) or 10
7 TCID50 (white bars)
Nipah virus. Nasal (A), oropharyngeal (B), urogenital (C) and
rectal (D) swabs were collected daily for 14 days and viral load in
the swabs was determined as TCID50 equivalents by real-time RT-
PCR. Geometric mean viral loads are displayed; error bars
indicate standard deviation.
(TIF)
Figure S2 Loss of bodyweight and survival in hamsters
inoculated with Nipah virus. Loss of bodyweight (A) and
survival (B) after intranasal inoculation of with 10
3 (solid line,
circles), 10
5 (dashed line, squares) or 10
7 (small dashed line,
triangles) TCID50 Nipah virus are plotted. Hamsters were
weighed daily, and the percentage of body weight was
calculated relative to the weight at time of inoculation. The
Figure 5. Transmission of Nipah virus. Shedding of Nipah virus in inoculated (left panels) and naı ¨ve (right panels) hamsters in fomite (A), direct
contact (B) and aerosol (C) transmission setups. Nasal (white bars) and oropharyngeal (black bars) were collected daily; viral load in the swabs was
determined as TCID50 equivalents by real-time RT-PCR. Geometric mean titers are displayed; error bars indicate standard deviation.
doi:10.1371/journal.pntd.0001432.g005
Nipah Virus Transmission
www.plosntds.org 8 December 2011 | Volume 5 | Issue 12 | e1432percentage of mice surviving the infection is shown as a
function of time.
(TIF)
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